Harnessing the power of artificial intelligence for clinical trials in cancer
AI is transitioning from conceptual promise to operational utility in oncology clinical research. As regulatory frameworks mature, harmonizing innovation with patient protection will be essential. When responsibly implemented, AI can bridge the gap between research and real-world care, transforming oncology trials into faster, fairer, and more reliable engines of discovery.
Authors
- Gamze Sönmez
- Yiğit Yazarkan (ORCID: https://orcid.org/0009-0000-8989-5207)
- Deniz Can Güven (ORCID: https://orcid.org/0000-0002-6924-9467)
- Taha Koray Sahin
Institutions
- Hacettepe University (TR)
Publication Details
- Journal
- Expert Review of Anticancer Therapy
- Published
- 2026-03-09
- DOI
- https://doi.org/10.1080/14737140.2026.2642221
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00